Mirae Asset Global Etfs Holdings Ltd. Apellis Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 9,198 shares of APLS stock, worth $272,076. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,198Holding current value
$272,076% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding APLS
# of Institutions
303Shares Held
113MCall Options Held
5.21MPut Options Held
691K-
Wellington Management Group LLP Boston, MA16.4MShares$485 Million0.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$343 Million15.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$329 Million5.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$290 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$171 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.25B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...